Skip to content

Clinical Study on Propofol-Induced Euphoria at Different Sedation Depths and Investigation of Its Electroencephalographic Mechanisms

Clinical Study on Propofol-Induced Euphoria at Different Sedation Depths and Investigation of Its Electroencephalographic Mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115566
Enrollment
Unknown
Registered
2025-12-29
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Propofol-induced euphoria

Interventions

Group B:Maintain the Narcotrend index within stage B0 to B2 (corresponding to an index range of 80–94).
Group C:Maintain the Narcotrend index within stage C0 to C2 (corresponding to an index range of 65-79).
Group D:Maintain the Narcotrend index within stage D0 to D1 (corresponding to an index range of 47-64).

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18 to 65 years old; 2. Body mass index (BMI) is between 18 and 30 kg/m ²; 3. American Society of Anesthesiologists (ASA) grade I to III, with no serious heart or lung systemic diseases; 4. It is planned to undergo elective lower limb surgery and receive intraspinal anesthesia. 5. It is planned to return to the general ward after the operation

Exclusion criteria

Exclusion criteria: 1.Allergic to propofol; 2. There is preoperative cognitive dysfunction or language communication disorder; 3. Long-term use of sedative, anti-anxiety or antidepressant drugs; 4. Pregnant or lactating women; 5. Have a history of hearing impairment or motion sickness

Design outcomes

Primary

MeasureTime frame
Incidence of (propofol-induced) euphoria;

Secondary

MeasureTime frame
Alterations in EEG features;Postoperative patient satisfaction;

Countries

China

Contacts

Public ContactXu Mao

Peking University Third Hospital

anae@163.com+86 189 1148 2830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026